论文部分内容阅读
为了探讨不同类型肾脏疾病与肾性骨病发生发展的关系，对１９９１年１～１１月诊治的６３例肾脏病患者用单光子吸收法（ｓｐＡ）测定尺、桡骨远端１／３处骨矿含量（ＢＭＣ）。６３例肾脏病患者按其肌酐清除率分Ａ、Ｂ、Ｃ３组。对比分析发现：ＢＭＣ测定值，Ａ组２７例中有２４例降低，Ｂ组２１例中有８例降低，Ｃ组全部在正常范围；ＢＭＣ测定值Ａ、Ｃ组间差异显著（Ｐ＜０．０５），Ｂ、Ｃ组间无显著差异（Ｐ＞０．０５）．说明ＢＭＣ测定值降低幅度与肌酐清除率的下降有显著的正相关系，血液透析时间与ＢＭＣ的降低幅度呈显著正相关。作者建议，可将ＢＭＣ测定用于临床监测慢性肾功能不全患者的骨代谢紊乱。
In order to explore the relationship between different types of kidney disease and the development of renal osteodystrophy, 63 patients with kidney disease diagnosed and treated from January 1991 to November 1991 were examined by single-photon absorption spectroscopy (SPA) Content (BMC). 63 cases of patients with kidney disease according to their creatinine clearance rate points A, B, C3 group. The results of BMC analysis showed that in group B, 24 cases were reduced in 27 cases, 8 cases in group B were reduced in 8 cases and group C was all in normal range. There was significant difference between group B and group B (P <0.05). 05), there was no significant difference between B and C groups (P> 0.05). This shows that there is a significant positive correlation between the decrease of BMC and the decrease of creatinine clearance. The hemodialysis time has a significant positive correlation with the decrease of BMC. The authors suggest that BMC assays may be used clinically to monitor bone metabolism disorders in patients with chronic renal insufficiency.